-Frontline Reinstatement of the fundamental right to property in the Constitution will on its own do little to protect the interests of poor peasants and traditional communities.  The Indian Constitution adopted in 1950 guaranteed a set of fundamental rights that cannot be abridged by Central or State laws. One of these fundamental rights was the right to property enshrined in Articles 19(1)(f) and 31. Article 19(1)(f) guaranteed to all citizens the right...

-The Hindu The work of India’s supreme auditor cannot be put through an audit unless the institution itself initiates one The relentless campaign against the Comptroller and Auditor-General, of an unprecedented ferocity, compels me to write again on the subject. First, has the CAG caused a political and constitutional crisis, as some have argued? All that the CAG does is to submit audit reports. Any audit report, if it is a good report,...

-The Times of India The Planning Commission may drop reference to crony capitalism in the plan document after protests from some ministers who are of the view that any mention would be a tacit acknowledgment of the existence of the practice. Besides, it has suggested "transparent auction" of natural resources as the solution, something that the government is not willing to accept as the one-size-fits-all approach for all sectors. Apart from crony capitalism,...

-PTI RJD's Delhi unit was disbanded by party chief Lalu Prasad on Saturday after the man, who protested against the Prime Minister at a conference here, was found to be the head of its state legal cell. "I strongly condemn it. Santosh Kumar Suman was made a member of the party by the Delhi state unit without verifying his credentials. He was made the in-charge (of the legal cell) one-and-half-year back," party...

-The Economic Times MUMBAI: In a victory to generic drugmakers, the Intellectual Property Appellate Board (IPAB) of Chennai has dismissed German pharma major Bayer's plea, seeking a stay on the Compulsory Licence issued to Hyderabad-based drugmaker Natco. The Compulsory Licence (CL) issued by the Controller of Patents in March this year allowed Natco to make and sell a generic version of Nexavar - used for treating liver and kidney cancer - at...